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Abstract The membrane topology of a resistance-nodulation-
division (RND) family transporter, MexD of Pseudomonas
aeruginosa, was determined. Although it had been predicted
previously that most RND proteins contain 12 transmembrane
helices, three independent computer programs used in the present
study predicted that MexD possessed 11, 14 or 17 transmem-
brane segments. To investigate the topology of MexD more
thoroughly, 25 MexD-PhoA (alkaline phosphatase) and 18
MexD-Bla (L-lactamase) fusion plasmids were constructed and
analyzed. The resulting topological model had just 12 transmem-
brane helices and two periplasmic loops of about 300 residues
between helices 1 and 2 and helices 7 and 8. It is therefore
proposed that the N- and C-termini are located in the cytoplasm
and the predicted orientation is consistent with the ‘positive-
inside rule’. This topological model can be applied to other RND
proteins.
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1. Introduction
The resistance-nodulation-division (RND) family proteins
have been identi¢ed in many bacteria involving multidrug
resistance [3,10,11,17,18,30], heavy-metal ion export
[16,22,33], transport of oligosaccharides [1] and extrusion of
hydrophobic solvent [14]. These proteins require the members
of two further protein families in order to function: the MFP
(membrane fusion protein) family proteins, which are prob-
ably localized in the periplasmic space, and the OMF (outer
membrane factor) family proteins, which facilitate passage of
a variety of substrates into external medium [27]. Members of
the RND family are considered to be proton-motive-force-
dependent transporters because no ATP-binding cassette has
been identi¢ed in their primary sequences and because the
reduced accumulation of substrates in the cells was restored
by addition of inhibitors of the cytoplasmic membrane proton
gradient [23^25]. Expression of functional RND transporters
in pathogenic bacteria such as Escherichia coli and Pseudomo-
nas aeruginosa is a signi¢cant problem because it confers in-
trinsic and acquired multiple drug resistance to these bacteria.
However, there is little information about mechanisms for
substrate recognition and transport across the cell envelope.
A prerequisite for a full investigation of these mechanisms is
the determination of the structure of the RND protein. To
this end computer-aided analyses of hydropathy and multiple
sequence alignment suggested that most of the RND family
proteins form 12 membrane spanning structures and have two
large periplasmic loops [10,26,28,31]. Here we report for the
¢rst time actual experimental evidence which con¢rms that the
membrane topology of an RND family transporter, MexD
from P. aeruginosa (an opportunistic pathogen exhibiting in-
nate multidrug resistance), consists of 12 transmembrane seg-
ments and two large periplasmic loops.
2. Materials and methods
2.1. Bacterial strains and culture conditions
P. aeruginosa strain PAO1 was used as a source of chromosomal
DNA for PCR ampli¢cation of the mexD gene. E. coli strains TG1
[34] and 8 [12] were used as hosts for plasmid construction and for
alkaline phosphatase assays, respectively. Bacterial strains were cul-
tured aerobically at 37‡C in LB medium [32] supplemented with ap-
propriate antibiotics if needed [8].
2.2. DNA techniques
Preparation of chromosome and plasmid DNA, and related in vitro
manipulation, agarose gel electrophoresis, transformation, restriction
endonuclease digestion, ligation and PCR were performed according
to established procedures [32].
2.3. Construction of mexD-phoA and mexD-bla fusion plasmids
To construct in-frame fusion of mexD-phoA and mexD-bla, the C-
terminally truncated mexD gene was ampli¢ed by PCR using chro-
mosome DNA extracted from P. aeruginosa PAO1 as a template.
PCR products containing truncated mexD-coding regions of various
sizes were blunt-ended with T4 DNA polymerase and phosphorylated
with T4 DNA kinase, followed by ligation to a unique SmaI site on
pPAB307 [4] for phoA fusion. These expressed alkaline phosphatase
(phoA) lacking signal sequences, under regulation by the tac promoter.
The same PCR fragments were also cloned into blunt-ended EcoRI
sites on pKMV011 for bla fusions. In this study, the construct was
prepared by slightly modifying pHSGamp1 [13], so that L-lactamase
without signal sequences was expressed dependent on the tac pro-
moter and constituting a unique EcoRI site between the promoter
and the bla gene. E. coli TG1 transformed with these plasmid con-
structs were screened by PCR ampli¢cation for the presence of the
fusion junction using the following primers: #mexD4, 5P-ATGTCC-
GAATTCTTCATCAAGC-3P, which anneals to the 5P terminus
downstream of mexD gene: and #phoA1, 5P-TTTATCGCTAAGA-
GAATCACGC-3P or #BLA1, 5P-AATAGTGTATGCGGC GACC-
G-3P, which anneal to the middle of the phoA or bla genes, respec-
tively, upstream of each gene. The presence of the fusion junctions of
the plasmids employed was con¢rmed by dideoxy chain termination
nucleotide sequencing using the Autocycle Sequencing kit (Pharma-
cia).
2.4. Immunodetection of MexD-PhoA fusions
To con¢rm whether strain 8 of E. coli, which lacks PhoA [12],
produces fused MexD-PhoA protein in-frame after transformation
with mexD-phoA fusion plasmids, cell envelopes were prepared after
induction with 1 mM isopropyl-L-D-thiogalactopyranoside (IPTG) at
37‡C for 2 h as described previously [6]. The envelope preparation was
solubilized with SDS-PAGE sample bu¡er [6] and subjected ¢rst to
electrophoresis and then to Western immunoblotting for detection of
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the PhoA component. For this purpose, rabbit anti-E. coli alkaline
phosphatase polyclonal antibody was used (Chemicon International).
Membrane-bound antibody was detected as described elsewhere [7].
2.5. PhoA assay and MIC measurement
The activity of PhoA expressed by E. coli strain 8 cells transformed
with mexD-phoA fusion plasmid was determined by the method of
Brickman and Beckwith [2]. Minimum inhibitory concentrations
(MICs) of ampicillin for E. coli TG1 transformed with mexD-bla
fusion plasmid were measured as described previously [6]. In both
cases, expression of fusion genes was induced by supplementation of
the culture media with 1 mM IPTG.
3. Results and discussion
3.1. Prediction of transmembrane helices of MexD
To predict the structure of the transmembrane region of
MexD, the amino acid sequence of MexD was analyzed using
computer programs for the prediction of hydrophobicity and
the presence of transmembrane helices. The proposed struc-
ture of RND proteins, for example E. coli AcrB, Neisseria
gonorrhoeae MtrD and P. aeruginosa MexB, consists of 12
transmembrane segments with two large periplasmic loops
[10,25,27]. The MexD amino acid sequence revealed a similar
hydropathy pro¢le to MexB [27] (Fig. 1), suggesting that it
has a 12 membrane-spanning structure. However, in spite of
the consistency of these ¢ndings, the computer programs used
for predicting transmembrane segments in this study provided
inconsistent models (Fig. 1). Therefore, to determine the
membrane topology of MexD experimentally, one sense prim-
er at the start of the MexD-coding sequence and 26 anti-
sense primers at various positions as indicated in Fig. 1
were designed and synthesized. These primers enabled the
analysis of all probable transmembrane segments predicted
in this study
3.2. Construction of mexD-phoA and mexD-bla fusion plasmids
Twenty-six PCR-ampli¢ed fragments encoding C-terminally
truncated MexD were cloned into plasmids carrying a gene
for PhoA lacking a signal sequence in order to construct
translational fusions. To test successful construction of these
MexD-PhoA fusions, cell envelopes prepared from transform-
ants harboring candidate plasmids were subjected to SDS-
PAGE for detection of fusion proteins by Western immuno-
blotting. Using an antibody speci¢c for PhoA, probable fu-
sion proteins with molecular masses greater than native PhoA
protein were detected (Fig. 2). However, one clone which was
expected to produce a fusion with the whole length of MexD
failed to demonstrate PhoA polypeptide and was therefore
excluded from the following analysis. Some of the fusions
showed proteolytic degradation products; this instability of
fusion proteins has been observed in other studies [21,35].
In addition, protein bands with higher molecular masses
than expected were observed; this might result from a low
Fig. 1. Hydropathy pro¢le, prediction of transmembrane helices of MexD and positions corresponding to PCR primers synthesized. The Pro-
tein Analysis program included in the MacVector software (Oxford Molecular Group) employs the Kyte and Doolittle algorithm [15] and was
used to assess the hydropathy (vertical axis) of an 11-amino acid interval as a function of the position in the protein (N- to C-terminus; hori-
zontal axis). Corresponding positions of transmembrane helices proposed by SOSUI (http://www. tuat.ac.jp/~mitaku/adv_SOSUI/), TopPred II
[5], and TMpred (http://ulrec3.unil.ch/software/TMPRED_form.html) programs are indicated by boxes. Shaded boxes show ¢ve putative trans-
membrane segments predicted by TopPred II. Arrowheads indicate positions and directions corresponding to synthesized PCR primers.
Table 1




(units Wg31 of protein)
MIC of ampicillin
(Wg ml31)
46 84.33 þ 7.28 NDc
85 52.01 þ 7.22 25
137 63.65 þ 16.23 50
191 42.33 þ 12.59 12.5
326 47.18 þ 10.15 50
361 7.91 þ 3.53 1.56
366 14.67 þ 2.73 ND
392 55.86 þ 15.53 50
424 5.99 þ 3.30 1.56
437 7.99 þ 2.03 ND
472 58.06 þ 6.50 ND
506 5.79 þ 1.78 ND
520 5.76 þ 0.84 1.56
530 12.58 þ 7.49 ND
579 50.95 þ 25.67 50
614 49.91 þ 2.63 ND
653 56.65 þ 17.59 50
707 37.32 þ 5.46 50
768 50.41 þ 14.08 12.5
840 65.32 þ 12.64 12.5
891 16.01 þ 2.26 1.56
920 53.26 þ 12.66 50
957 6.44 þ 2.82 1.56
968 7.42 þ 3.96 ND
998 60.73 þ 14.25 25
1043 ND 1.56
aFusion junctions are shown by the residue number of the MexD
amino acid sequence.
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solubility of these fusion proteins, because the samples were
subjected to SDS-PAGE without heating in sample bu¡er [9].
Although di¡erent amounts of fusion proteins were detected
(as shown in Fig. 2), there was no correlation between the
level of PhoA activity and the amount of MexD-PhoA fusion
protein (data not shown). On the other hand, 18 of 26 PCR
fragments used above were also cloned into plasmids carrying
a gene for L-lactamase lacking a signal sequence. Thus,
25 MexD-PhoA fusions were successfully constructed and
an additional 18 mexD-bla clones were prepared to analyze
the membrane topology of MexD.
3.3. PhoA activity and ampicillin susceptibility of fusions in
intact cells
The alkaline phosphatase activity of the intact E. coli cells
producing MexD-PhoA fusions was measured. These assays
revealed various levels of activity which could be classi¢ed
roughly into two groups of relatively high (v37.32 þ 5.46
units, fusion at residue 707) and low (916.01 þ 2.26, at residue
891) values (Table 1) consisting of 15 and 10 clones, respec-
tively. Moreover, these two groups were clustered into six and
¢ve consecutive regions. Since alkaline phosphatase functions
in the periplasmic space, but not in the cytoplasm [19], the
fusion sites of MexD-PhoA belonging to the high-activity
group were presumably located in the periplasm, and in con-
trast, those of the low-activity group were expected to be
distributed in the cytoplasm. Taken together, the results
from analyses of the PhoA-fusion constructs suggest that
MexD has six periplasmic and ¢ve cytoplasmic regions; in
other words, it must contain at least 10 membrane-spanning
moieties.
To con¢rm this hypothesis, 18 clones harboring mexD-bla
fusion plasmids were analyzed. On the basis of the MICs of
ampicillin against mexD-bla-carrying strains, these clones
were divided into two groups: (1) sensitive (MIC: 1.56 Wg
ml31) and (2) resistant (MIC: over 12.5 Wg ml31), consisting
of 6 and 12 fusions, respectively (Table 1). Because L-lactam-
ase also has hydrolytic activity when translocated into the
periplasm, it is suggested that the resistant strains produce
MexD-Bla fusion proteins in which the L-lactamase moiety
is located in the periplasmic space. Although it was not di-
rectly determined whether all 18 clones successfully produce
MexD-Bla fusion proteins, at least 12 clones revealing ampi-
cillin resistance were very likely to have produced the fusion
proteins. This result was completely consistent with that from
PhoA fusion experiments and strongly supported the predic-
tion that MexD has at least 10 membrane-spanning segments.
3.4. The MexD topological model
Although the PhoA- or Bla-fusion experiments resulted in
the conclusion that MexD has at least 10 transmembrane
helices, distribution of the N- and C-termini could not be
identi¢ed. However, all three computer programs used in
this study proposed the existence of transmembrane segments
between the N-terminus and the ¢rst periplasmic loop, and
between the sixth periplasmic loop and the C-terminus. There-
fore, it was suggested that MexD has 12 transmembrane heli-
ces with N- and C-termini located in the cytoplasm. Fig. 3
shows the MexD membrane topology model determined in
this study. This model is based on the ‘certain’ transmem-
brane segments predicted by TopPred II for the following
reasons. First, ¢ve ‘putative’ transmembrane segments pre-
dicted by TopPred II (amino acid residues 49^69, 124^144,
600^620, 732^752, and 785^805) and two transmembrane re-
gions by TMpred (residues 603^629 and 786^805) (see Fig. 1)
could not be considered membrane-spanning domains because
no change in the distribution of PhoA and Bla moieties was
observed between the N- and C-sides of these regions (Table
1). Second, the third transmembrane domain predicted by
SOSUI (residues 382^404) could not be considered a mem-
brane-spanning domain because PhoA fusion at residue 392
in this region exhibited apparently high activity. Third, the
existence of a transmembrane domain between residues 366
and 392, and between 392 and 424 is suggested because PhoA
activities at residue 366 and 424 are low, in contrast to the
high activity of residue 392 (see Fig. 1 and Table 1). Taken
together, this model suggest that the 1043 residues of MexD
are distributed to three subcellular compartments: 130
(12.5%) residues in the cytoplasm, 666 (63.9%) residues in
the periplasm and 247 (23.7%) residues in the membrane.
Such a structure behaves in accordance with the positive-in-
side rule [36] as follows. The cytoplasmic domain consisting of
Fig. 2. Western immunoblotting of MexD-PhoA fusions. After induction with 1 mM IPTG, cell envelopes of E. coli 8 transformants prepared
as described previously [6] were subjected to SDS-PAGE and analyzed by immunodetection using anti-PhoA antibody. Lanes contained 20 Wg
of total envelopes of strains harboring the mexD-phoA fusion plasmids carrying the indicated MexD amino acid residues. Calculated molecular
masses of fusions are: 1^46 (52.3 kDa), 1^85 (56.3 kDa), 1^137 (61.9 kDa), 1^191 (67.9 kDa), 1^326 (82.4 kDa), 1^361 (86.5 kDa), 1^366
(87.1 kDa), 1^392 (89.9 kDa), 1^424 (93.4 kDa), 1^437 (94.7 kDa), 1^472 (98.3 kDa), 1^506 (101.9 kDa), 1^520 (103.6 kDa), 1^530 (104.8
kDa), 1^579 (110.2 kDa), 1^614 (114.0 kDa), 1^653 (118.2 kDa), 1^707 (123.8 kDa), 1^768 (130.4 kDa), 1^840 (138.2 kDa), 1^891 (143.7
kDa), 1^920 (146.6 kDa), 1^957 (150.8 kDa), 1^968 (152.0 kDa), and 1^998 (155.0 kDa). The left panel shows fractionations done in 10%
polyacrylamide gels and the right panel 8% gels. The positions of molecular mass markers are indicated in kDa. Arrowheads indicate the posi-
tions of each fusion protein.
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¢ve loops (CL 1^5, Fig. 3) with N- and C-termini is con-
structed from 130 residues and contains 24 (18.5%) positively
charged residues (R, H and K) in contrast to the six periplas-
mic loops (666 residues) and 12 transmembrane segments (247
residues) which have only 61 (9.2%) and four (1.6%) basic
amino acids, respectively. A typical predicted structure for
MexD implies the existence of two large periplasmic loops
(PL1 and PL4, Fig. 3) each consisting of about 300 amino
acid residues. Such a set of very large loops is likely to be a
typical structure for RND family transporters but not for
other proton-motive-force-dependent e¥ux proteins and
ABC transporters [26]. MexD has a high degree of homology
(38^49%) with other RND family proteins including multi-
drug e¥ux proteins, AmrB of Burkholderia pseudomallei
[20], MexB of P. aeruginosa [28,29], AcrB of E. coli [18],
MtrD of N. gonorrhoeae [11], CeoB of Burkholderia cepacia
[3] and organic solvent resistance protein, SrpB of Pseudomo-
nas putida [14]. The predicted sequence alignments and mem-
brane-spanning helices indicated that these proteins have a
very similar topological organization (data not shown), sug-
gesting that the topological model proposed for P. aeruginosa
MexD can be used to predict the topologies of the other RND
family members.
The results of this study cannot distinguish between trans-
membrane segments and hydrophilic loops at the levels of one
single amino acid residue. However, at least MexD, one of the
RND family transporters, has a 12 membrane-spanning struc-
ture with two large periplasmic loops. There are no data on
the function(s) of these typical domains, which may be needed
for binding to other co-functional protein(s) such as MFP
family members. More detailed mutational analysis taking
into account the experimentally determined membrane topol-
ogy of MexD in this study will enhance our understanding of
the functional mechanisms utilized by members of the RND
family of broad substrate-recognizing transporters.
During the preparation of this article, a paper by Guan et
al. [9] appeared, in which it was demonstrated experimentally
that MexB, a homologue of MexD, possesses 12 transmem-
brane domains. The results from this independent study ac-
cord with our own results presented here.
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